News

CENTOGENE AG announces the exclusive strategic partnership for genetic testing in Saudi-Arabia with ELAJ Group, the holding company of AL Borg Medical…

Sequencing analysis has become a valuable approach for diagnostics of rare diseases. The increasing numbers of analysed genes with a not clearly…

Hand-over of the donation of the Rare Disease Day Run 2015 - Weekends off for families with chronically ill and handicapped children.

For several…

Centogene GmbH, Germany, and Filgen Inc. are pleased to announce the start of a long-term  exclusive partnership in Japan as of October 2015. The…

With the groundbreaking ceremony for CENTOGENE’s new headquarter in Rostock, the construction phase of Europe’s most innovative center for molecular…

Comparative genomic hybridization (CGH) is a molecular cytogenetic technique for analyzing copy number variations. Array CGH (aCGH) allows us to…

Centogene GmbH (CENTOGENE) and Amarey Nova Medical Group (Amarey) are pleased to announce a strategic exclusive partnership in Colombia, as of…

CENTOGENE is proud to announce that Prof Peter Bauer/Medical University Tübingen, Germany will join CENTOGENE GmbH in January 2016 as Chief Operating…

To watch the video please click here.

On August 8^th, against a backdrop of splendid maritime scenery provided by the famous Hanse Sail 2015, 400 VIP…

CENTOGENE is proud to announce its preferred partnership in the topic of modern molecular genetic testing in India together with the Centre of Medical…